Naproxen Capsules

This product is a non-steroidal anti-inflammatory drug that can inhibit the synthesis of prostaglandins and exert anti-inflammatory and analgesic effects.

Each tablet of this product contains 0.2g of naproxen, the main ingredient. The auxiliary materials are microcrystalline cellulose, pregelatinized starch, sodium carboxymethyl cellulose and magnesium stearate.

This product is a hard capsule containing white or off-white crystalline powder; odorless or almost odorless.

It is used to treat rheumatic and rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, arthritis, and tenosynovitis. It can also be used to relieve pain caused by sprains, contusions, injuries, and dysmenorrhea of bones and flesh.

Oral administration: Adults take 2 capsules for the first time, 1 capsule each time thereafter, and once every 6-8 hours if necessary.

(1) Skin itching, shortness of breath, dyspnea, asthma, tinnitus, lower limb edema, stomach burning sensation, indigestion, stomach pain or discomfort, constipation, dizziness, drowsiness, headache, nausea and vomiting, etc. (2) Blurred vision or visual impairment, hearing loss, diarrhea, oral irritation or pain, palpitations and excessive sweating, etc. (3) Gastrointestinal bleeding, kidney damage (allergic nephritis, kidney disease, renal papillary necrosis and renal failure, etc.), urticaria, allergic rash, depression, muscle weakness, bleeding or granulocytopenia and liver damage are less common.

This product should not be used by people with a history of allergy to this type of drug, or those who have experienced asthma, rhinitis, or nasal polyposis syndrome caused by aspirin or other non-steroidal anti-inflammatory drugs.

(1) When drinking alcohol or taking it with other nonsteroidal anti-inflammatory drugs, gastrointestinal adverse reactions increase and there is a risk of ulcers. (2) When used with anticoagulants such as heparin and dicoumarol, the bleeding time is prolonged. Bleeding tendency may occur and there is a possibility of causing gastrointestinal ulcers. (3) This product can reduce the sodium excretion and hypotensive effect of furosemide. (4) This product can inhibit the excretion of lithium in the urine and increase the blood concentration of lithium. (5) When used with probenecid, the blood concentration of this product increases and T1/2 is prolonged. It can increase the efficacy, but the toxic reaction is also increased accordingly.

Keep in a dark place and sealed (10-30℃).

0.2g

36 months